DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
97	潰瘍性大腸炎	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04000139 (ClinicalTrials.gov)	April 1, 2019	24/6/2019	Anthocyanin Rich Extract (ACRE) in Patients With Ulcerative Colitis	A Multi-center, Multi-national, Randomized, Double-blind, Placebo Controlled, Parallel Group, Phase IIa Study to Evaluate the Efficacy, Safety and Tolerability of an Anthocyanin-rich Extract (ACRE) in Patients With Ulcerative Colitis	Ulcerative Colitis	Drug: Standardized anthocyanin-rich extract;Drug: Placebo	University of Zurich	Swiss National Science Foundation;The Broad Foundation	Recruiting	18 Years	N/A	All	120	Phase 2	Switzerland

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT04000139
(ClinicalTrials.gov)

April 1, 2019

24/6/2019

Anthocyanin Rich Extract (ACRE) in Patients With Ulcerative Colitis

A Multi-center, Multi-national, Randomized, Double-blind, Placebo Controlled, Parallel Group, Phase IIa Study to Evaluate the Efficacy, Safety and Tolerability of an Anthocyanin-rich Extract (ACRE) in Patients With Ulcerative Colitis

Ulcerative Colitis

Drug: Standardized anthocyanin-rich extract;Drug: Placebo

University of Zurich

Swiss National Science Foundation;The Broad Foundation

Recruiting

18 Years

N/A

All

120

Phase 2

Switzerland